American Association for Cancer Research: Oncolytic Herpesvirus Shows Early Promise in Pediatric Patients With High-Grade Glioma
April 10, 2021
April 10, 2021
PHILADELPHIA, Pennsylvania, April 10 (TNSJou) -- The American Association for Cancer Research issued the following news release:
Treatment with a modified herpesvirus in combination with radiation therapy was well tolerated and showed signs of clinical efficacy in pediatric patients with high-grade glioma, according to data from a phase I clinical trial presented during Week 1 of the virtual AACR Annual Meeting 2021, held April 10-15.
Data from this trial were concurren . . .
Treatment with a modified herpesvirus in combination with radiation therapy was well tolerated and showed signs of clinical efficacy in pediatric patients with high-grade glioma, according to data from a phase I clinical trial presented during Week 1 of the virtual AACR Annual Meeting 2021, held April 10-15.
Data from this trial were concurren . . .